BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22334158)

  • 1. Impact of fundal extension on hearing after surgery for vestibular schwannomas.
    Nguyen QT; Wu AP; Mastrodimos BJ; Cueva RA
    Otol Neurotol; 2012 Apr; 33(3):455-8. PubMed ID: 22334158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2.
    Friedman RA; Goddard JC; Wilkinson EP; Schwartz MS; Slattery WH; Fayad JN; Brackmann DE
    Otol Neurotol; 2011 Dec; 32(9):1530-7. PubMed ID: 21986931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve of origin, tumor size, hearing preservation, and facial nerve outcomes in 359 vestibular schwannoma resections at a tertiary care academic center.
    Jacob A; Robinson LL; Bortman JS; Yu L; Dodson EE; Welling DB
    Laryngoscope; 2007 Dec; 117(12):2087-92. PubMed ID: 17921903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vestibular schwannoma volume as a predictor of hearing outcome after surgery.
    Gjuric M; Mitrecic MZ; Greess H; Berg M
    Otol Neurotol; 2007 Sep; 28(6):822-7. PubMed ID: 17554228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing preservation and facial nerve outcomes in vestibular schwannoma surgery: results using the middle cranial fossa approach.
    Arts HA; Telian SA; El-Kashlan H; Thompson BG
    Otol Neurotol; 2006 Feb; 27(2):234-41. PubMed ID: 16436995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Middle fossa approach for resection of vestibular schwannoma: impact of cochlear fossa extension and auditory monitoring on hearing preservation.
    Vincent C; Bonne NX; Guérin C; Lebreton JP; Devambez M; Dubrulle F; Haddad E; Schapira S; Lejeune JP; Vaneecloo FM
    Otol Neurotol; 2012 Jul; 33(5):849-52. PubMed ID: 22699993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional outcome of retrosigmoid approach in vestibular schwannoma surgery.
    Yang J; Grayeli AB; Barylyak R; Elgarem H
    Acta Otolaryngol; 2008 Aug; 128(8):881-6. PubMed ID: 18607969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
    Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
    Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hearing preservation in conservation surgery for vestibular schwannoma.
    Holsinger FC; Coker NJ; Jenkins HA
    Am J Otol; 2000 Sep; 21(5):695-700. PubMed ID: 10993461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of nerve branch of origin and extracanalicular extension of the tumor on hearing after middle fossa removal of vestibular schwannoma.
    Fiscina F; Gouveris H; Mann W
    Acta Otolaryngol; 2007 Oct; 127(10):1058-61. PubMed ID: 17851965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fundal fluid as a predictor of hearing preservation in the middle cranial fossa approach for vestibular schwannoma.
    Goddard JC; Schwartz MS; Friedman RA
    Otol Neurotol; 2010 Sep; 31(7):1128-34. PubMed ID: 20657334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term hearing preservation after middle fossa removal of vestibular schwannoma.
    Friedman RA; Kesser B; Brackmann DE; Fisher LM; Slattery WH; Hitselberger WE
    Otolaryngol Head Neck Surg; 2003 Dec; 129(6):660-5. PubMed ID: 14663432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of facial nerve function results after translabyrinthine and retrosigmoid approach in medium-sized tumors.
    Mamikoglu B; Esquivel CR; Wiet RJ
    Arch Otolaryngol Head Neck Surg; 2003 Apr; 129(4):429-31. PubMed ID: 12707190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acoustic neuromas presenting with normal or symmetrical hearing: factors associated with diagnosis and outcome.
    Lustig LR; Rifkin S; Jackler RK; Pitts LH
    Am J Otol; 1998 Mar; 19(2):212-8. PubMed ID: 9520059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Hearing Preservation Outcomes for Small Vestibular Schwannomas: Retrosigmoid Removal Versus Observation.
    Zhu W; Chen H; Jia H; Chai Y; Yang J; Wang Z; Wu H
    Otol Neurotol; 2018 Feb; 39(2):e158-e165. PubMed ID: 29315192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrosigmoid versus middle fossa surgery for small vestibular schwannomas.
    Mangham CA
    Laryngoscope; 2004 Aug; 114(8):1455-61. PubMed ID: 15280726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsurgical factors predictive of postoperative hearing for patients with vestibular schwannoma.
    Robinette MS; Bauch CD; Olsen WO; Harner SG; Beatty CW
    Am J Otol; 1997 Nov; 18(6):738-45. PubMed ID: 9391670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of transient-evoked otoacoustic emissions for hearing preservation in acoustic neuroma surgery.
    Filipo R; Delfini R; Fabiani M; Cordier A; Barbara M
    Am J Otol; 1997 Nov; 18(6):746-9. PubMed ID: 9391671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durability of hearing preservation after microsurgical treatment of vestibular schwannoma using the middle cranial fossa approach.
    Wang AC; Chinn SB; Than KD; Arts HA; Telian SA; El-Kashlan HK; Thompson BG
    J Neurosurg; 2013 Jul; 119(1):131-8. PubMed ID: 23413947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.